![]() |
市場調查報告書
商品編碼
1492504
消費者基因組學市場:按產品/服務、技術、應用分類 - 2024 年至 2030 年全球預測Consumer Genomics Market by Product & Service (Consumables, Services, Systems & Software), Technology (Microarray, Nucleic Acid Extraction & Purification, Polymerase Chain Reaction (PCR)), Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年消費者基因組市場規模為25.6億美元,預計2024年將達31億美元,2030年將達到100.8億美元,複合年成長率為21.62%。
消費者基因組學分析個人的基因組成,提供對遺傳、某些健康狀況的傾向、對藥物的潛在反應以及其他個人特徵的深入了解。此資訊通常透過直接面對消費者 (DTC) 的基因檢測套組提供。然後在實驗室中對 DNA 進行分析,並透過安全的線上平台提供結果。隨著人們健康意識的增強,對從遺傳訊息中獲得的個人化健康見解的興趣與日俱增,消費者對基因組相關產品的需求也在增加。人們對遺傳疾病的認知和診斷不斷提高,鼓勵個人了解自己的遺傳風險並積極管理自己的健康。然而,基因檢測結果的準確性和可靠性各不相同,並受到基因資料解釋技術和品質的影響。對基因資料隱私和基因檢測的倫理影響的擔憂可能會阻止個人使用這些服務。持續的研究和開發將開發出更先進、更準確和更具成本效益的基因組測試技術,擴大消費者基因組學的範圍和吸引力。消費者基因組學有潛力為個人化醫療領域做出重大貢獻,該領域支持根據個人基因圖譜量身定做的治療方法。
主要市場統計 | |
---|---|
基準年[2023] | 25.6億美元 |
預測年份 [2024] | 31億美元 |
預測年份 [2030] | 100.8億美元 |
複合年成長率(%) | 21.62% |
區域洞察
在美洲,特別是在美國,消費者基因組學市場高度發達,並受到消費者對個人化健康見解的傾向的推動。由於廣泛的教育舉措和廣泛的行銷,美洲地區的消費者對基因組學的認知非常高。現代技術的高度普及和生物技術的大量投資正在推動該地區的成長。在歐洲,英國、德國、法國等國家由於消費者意識高、健康意識強而處於領先地位。基因組學研究和開發得到政府資金的大力支持,特別是在這些國家。歐盟 (EU) 關於基因資料的嚴格隱私法規也確保消費者權利得到充分保護,從而顯著影響注重隱私的產品的市場動態。亞太地區代表了消費者基因組學的發展,人們對健康和保健、遺傳疾病的認知不斷提高,政府大力支持,對生物技術研究進行了大量投資。開發負擔得起的家庭基因檢測套組的努力有可能推動消費者基因組市場的發展。
FPNV定位矩陣
FPNV 定位矩陣對於評估供應商在消費者基因組學市場的定位至關重要。此矩陣提供了對供應商的全面評估,並檢查了與業務策略和產品滿意度相關的關鍵指標。這種詳細的評估使用戶能夠根據自己的要求做出明智的決定。根據評估,供應商被分為代表其成功程度的四個像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對消費者基因組學市場供應商的現狀進行深入而詳細的評估。透過仔細比較和分析供應商的貢獻,您可以更深入地了解每個供應商的績效以及他們在爭奪市場佔有率時面臨的挑戰。這些貢獻包括整體收益、客戶群和其他重要指標。此外,該分析還提供了對該行業競爭力的寶貴見解,包括在研究基準年期間觀察到的累積、分散主導地位和合併特徵等因素。有了這些詳細資訊,供應商可以做出更明智的決策並製定有效的策略,以在市場競爭中保持領先地位。
策略分析與建議
策略分析對於尋求在全球市場站穩腳跟的組織至關重要。透過徹底評估其目前在消費者基因組學市場中的地位,公司可以做出符合其長期願望的明智決策。此關鍵評估涉及對組織的資源、能力和整體績效進行徹底分析,以確定核心優勢和需要改進的領域。
[189 Pages Report] The Consumer Genomics Market size was estimated at USD 2.56 billion in 2023 and expected to reach USD 3.10 billion in 2024, at a CAGR 21.62% to reach USD 10.08 billion by 2030.
Consumer genomics involves the analysis of an individual's genetic makeup to provide insights into heritage, predisposition to certain health conditions, potential response to medications, and other personal traits. This information is typically provided using direct-to-consumer (DTC) genetic testing kits, which consumers can use at home by providing a DNA sample through saliva or a cheek swab. The DNA is then analyzed in a lab, and results are delivered through secure online platforms. As people become more health-conscious, there is a growing interest in personalized health insights derived from genetic information, leading to an increased need for consumer genomic products. There is an increasing awareness and diagnosis of genetic disorders, encouraging individuals to understand their genetic risks and manage health proactively. However, there can be variability in the accuracy and reliability of genetic testing results, influenced by the quality of technology and interpretation of genetic data. Concerns about the privacy of genetic data and the ethical implications of genetic testing can deter individuals from using these services. Ongoing research and development are likely to result in more advanced, accurate, and cost-effective genomic testing technologies, broadening the scope and appeal of consumer genomics. Consumer genomics has the potential to contribute significantly to the field of personalized medicine, helping tailor medical treatments to individuals' genetic profiles.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 2.56 billion |
Estimated Year [2024] | USD 3.10 billion |
Forecast Year [2030] | USD 10.08 billion |
CAGR (%) | 21.62% |
Regional Insights
In the Americas, particularly in the United States, the consumer genomics market is highly developed and driven by a consumer's inclination toward personalized health insights. The Americas region boasts a significant level of consumer awareness about genomics, owing to extensive educational initiatives and widespread marketing. High penetration of modern technology and substantial investments in biotechnology fuel the growth in this region. Europe presents a diverse landscape in consumer genomics, with countries such as the UK, Germany, and France leading due to high consumer awareness and health-conscious populations. Research and development in genomics are strongly supported by government funding, particularly in these countries. The European Union's stringent privacy regulations on genetic data also ensure consumer rights are adequately protected, influencing the market dynamics heavily towards privacy-conscious offerings. APAC region represents an evolving landscape for consumer genomics, driven by rising awareness about health and wellness and genetic diseases, significant government backing, and substantial investments in biotechnology research. Efforts to develop affordable, home-based genetic testing kits have the potential to boost the consumer genomics market.
Market Insights
The market dynamics represent an ever-changing landscape of the Consumer Genomics Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Consumer Genomics Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Consumer Genomics Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Launch of Nucleus Genomics' Comprehensive DNA Analysis Services
Nucleus Genomics has introduced a novel DNA analysis product designed to enhance personalized medicine accessibility. The company is also initiating pre-orders for its advanced whole-genome sequencing service, aiming for a detailed analysis of a customer's complete DNA set. [Published On: 2024-03-25]
Strategic Partnership Expansion Between DnaNudge and NantNudge to Enhance Global Access to Genomics and AI-Driven Diagnostics
DnaNudge entered into a significant multi-million-dollar partnership with NantNudge, a company focused on advancing genomics combined with artificial intelligence at the point of decision. This collaboration aims to extend lab-free, rapid diagnostic solutions globally, particularly in the Americas and Africa. NantNudge will be responsible for creating and supplying cutting-edge diagnostic tools tailored for non-invasive health monitoring, dietary, and skincare advisement, alongside real-time PCR diagnostics for infectious diseases and cancers. [Published On: 2023-11-06]
Quest Diagnostics Unveils 'Genetic Insights': A New Consumer-Centric Genetic Testing Service
Quest Diagnostics has introduced 'Genetic Insights,' a consumer-oriented genetic testing service aimed at assessing the risk for inheritable diseases. The test uses a saliva sample to analyze 36 genes to predict the risk for 24 genetic conditions, such as breast and colon cancers, cardiovascular and blood disorders, and carrier status for diseases such as cystic fibrosis, sickle cell anemia, and Tay-Sachs disease. The service also offers personalized health reports and access to genetic counseling, enhancing individual understanding of their genetic health landscape. [Published On: 2023-07-11]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Consumer Genomics Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Consumer Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 23andMe, Inc., Agilent Technologies, Inc., Ambry Genetics Corporation by Konica Minolta, Inc., Ancestry, BGI Group, Bio-Rad Laboratories, Inc., Color Health, Inc., Dante Labs Inc., Decode Genetics by Amgen Inc., Eurofins Scientific SE, F. Hoffmann-La Roche Ltd, Full Genomes Corporation, Inc., Gene by Gene, Ltd., Helix OpCo, LLC, Illumina, Inc., Invitae Corporation, Living DNA Ltd, MyHeritage Ltd., Nebula Genomics, Inc. by ProPhase Labs, Inc., Oxford Nanopore Technologies PLC, QIAGEN GmbH, SeqLL Inc., Thermo Fisher Scientific, Inc., and Veritas Intercontinental SL by LetsGetChecked, Inc..
Market Segmentation & Coverage